Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges

出版年份 2017 全文链接

标题

作者

关键词

Non-small-cell lung cancer, Immune checkpoint inhibitor, Pembrolizumab, Nivolumab, Atezolizumab, PDL1, PD1

出版物

Volume 78, Issue -, Pages 16-23

出版商

Elsevier BV

发表日期

2017-04-11

DOI

10.1016/j.ejca.2016.12.041

联系作者

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started